ALKEM Stock View

Alkem Laboratories Ltd

ALKEM Stock View

(NSE)

Trade

₹ 3,395.7

27.35 | 0.81

Market Cap ₹( Cr.)
406,006.90

Proj. P/E (x)
25.35

Proj. P/BV (x)
3.90

Proj. ROE (%)
15.96

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
130,763.57

HOLD

Last Updated On.
04-Jun-2023

 

Copy Link

Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company operates through pharmaceuticals segment. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and approximately 50 countries internationally. The Company offers its products across various therapeutic areas, such as anti-infective, dermatology, diabetology, cardiology, gastroenterology, osteoporosis, Rheumatology, central nervous system (CNS), oncology, urology and gynecology. The Company offers its products under various brands, including Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Gemcal, Taxim, Sumo, Maxvoid Plus, Tamsukem Plus and Neurokem NT. The Company has approximately 20 manufacturing facilities, of which 18 manufacturing facilities are located in India and two in the United States.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data